Tirzepatide Offers Better A1c and Post-Meal Glucose Control

Tirzepatide was more effective than basal insulins in reducing A1c and postprandial glucose levels in a post hoc analysis.
Medscape Medical News

source https://www.medscape.com/viewarticle/tirzepatide-offers-better-glucose-control-regardless-2024a1000699?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost